These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 6853199)

  • 1. Dose revision for A-bomb survivors and the question of fallout contribution.
    Schmitz-Feuerhake I
    Health Phys; 1983 Jun; 44(6):693-5. PubMed ID: 6853199
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dose-effect relationships in Hiroshima and Nagasaki and the evaluation of radiation risks taking into account the fallout dose].
    Schmitz-Feuerhake I; Carbonell P; Wellner R
    Strahlenschutz Forsch Prax; 1985; 25():229-37. PubMed ID: 21452582
    [No Abstract]   [Full Text] [Related]  

  • 3. "Radiation-induced" cancer.
    Cember H
    Science; 1989 Sep; 245(4922):1031-2. PubMed ID: 2772653
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
    Little MP
    Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the mortality of A-bomb survivors. 4. Mortality and radiation dose, 1950-1966.
    Beebe GW; Kato H; Land CE
    Radiat Res; 1971 Dec; 48(3):613-49. PubMed ID: 5137468
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biological effects and mortality in connection with low dosage ionizing radiation].
    Henriksen JH
    Ugeskr Laeger; 2001 Jan; 163(1):44-5. PubMed ID: 11586674
    [No Abstract]   [Full Text] [Related]  

  • 7. Leukaemic mycosis fungoides in an atomic bomb survivor with lung and renal cancers.
    Shimauchi T; Nishio D; Isoda H; Sugita K; Kabashima K; Tokura Y
    Clin Exp Dermatol; 2009 Oct; 34(7):e322-4. PubMed ID: 19456778
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
    Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
    Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A-bomb data: detection of bias in the Life Span Study cohort.
    Stewart A
    Environ Health Perspect; 1997 Dec; 105 Suppl 6(Suppl 6):1519-21. PubMed ID: 9467075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral multiple primary tumours in an atomic-bomb survivor.
    Morishita M; Ohtsurut A; Nakashima M; Yamashita S
    Clin Oncol (R Coll Radiol); 2005 Aug; 17(5):391-2. PubMed ID: 16097573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCI apologizes for fallout study delay.
    Wadman M
    Nature; 1997 Oct; 389(6651):534. PubMed ID: 9335478
    [No Abstract]   [Full Text] [Related]  

  • 12. Thoughts on the nuclear age.
    Thompson RH
    Ohio State Med J; 1983 Jun; 79(6):403, 405, 407. PubMed ID: 6634010
    [No Abstract]   [Full Text] [Related]  

  • 13. [Health effects of atomic bomb radiation].
    Shigematsu I
    Rinsho Byori; 1994 Apr; 42(4):313-9. PubMed ID: 8176838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of non-cancer diseases in atomic bomb survivors.
    Kodama K; Fujiwara S; Yamada M; Kasagi F; Shimizu Y; Shigematsu I
    World Health Stat Q; 1996; 49(1):7-16. PubMed ID: 8896251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary tumors following fallout radiation exposure.
    Adams WH; Harper JA; Rittmaster RS; Grimson RC
    JAMA; 1984 Aug; 252(5):664-6. PubMed ID: 6737672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation from bomb tests could cause thyroid cancer, but screening program not advisable. US National Academy Press.
    J Radiol Prot; 1998 Dec; 18(4):303-4. PubMed ID: 9915646
    [No Abstract]   [Full Text] [Related]  

  • 17. Salivary gland tumors among atomic bomb survivors, 1950-1987.
    Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
    Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study focuses on genetic fallout of the bomb.
    Cyranoski D
    Nature; 2001 Jan; 409(6816):5. PubMed ID: 11343078
    [No Abstract]   [Full Text] [Related]  

  • 19. [The distinctive characteristics of malignant neoplasms in the population of the Altai Territory subjected to long-term radiation exposure as a consequence of the multiyear nuclear explosives tests at the Semipalatinsk proving ground].
    Lazarev AF; Shoĭkhet IaN; Petrova VD
    Vopr Onkol; 1995; 41(2):23-5. PubMed ID: 7483423
    [No Abstract]   [Full Text] [Related]  

  • 20. Risks from depleted uranium.
    Jones S; Lowles I; Smith A
    Lancet; 2001 May; 357(9267):1532. PubMed ID: 11383545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.